Lipoxin A(4) attenuates obesity-induced adipose inflammation and associated liver and kidney disease

The role of inflammation in obesity-related pathologies is well established. We investigated the therapeutic potential of LipoxinA(4) (LXA(4):5(S),6(R),15(S)-trihydroxy-7E,9E,11Z,13E,-eicosatetraenoic acid) and a synthetic 15(R)-Benzo-LXA(4)-analogue, as interventions in a 3-month high-fat-diet [HFD...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Metab
Autors principals: Börgeson, Emma, Johnson, Andrew M.F., Lee, Yun Sok, Till, Andreas, Syed, Gulam Hussain, Ali-Shah, Syed Tasadaque, Guiry, Patrick J., Dalli, Jesmond, Colas, Romain A., Serhan, Charles N., Sharma, Kumar, Godson, Catherine
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4584026/
https://ncbi.nlm.nih.gov/pubmed/26052006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2015.05.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars